SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nukkleus Inc. (NUKK) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 8/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — NUKK
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-35.29
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$0.00 |
$9.7M |
$-260K |
-2.7% |
| 2017 |
$0.00 |
$24M |
$-137K |
-0.6% |
| 2018 |
$-0.03 |
$19.2M |
$-212K |
-1.1% |
| 2019 |
$-0.03 |
$19.2M |
$-730K |
-3.8% |
| 2020 |
$0.00 |
$19.2M |
$-101K |
-0.5% |
| 2021 |
$-0.13 |
$19.29M |
$-936.85K |
-4.9% |
| 2022 |
$-1.65 |
$21.51M |
$-11.85M |
-55.1% |
| 2023 |
$-13.84 |
$16.22M |
$-17.43M |
-107.4% |
| 2024 |
$-0.59 |
$5.91M |
$-8.52M |
-144.1% |
| 2025 |
$-35.29 |
$0.00 |
$-71.18M |
- |
